Simultaneous Targeting Tumor Cells and Cancer-Associated Fibroblasts with a Paclitaxel-Hyaluronan Bioconjugate: In Vitro Evaluation in Non-Melanoma Skin Cancer.

Barbara BelleiSilvia CaputoEmilia MiglianoGianluca LopezValeria MarcacciniCarlo CotaMauro Picardo

Published in: Biomedicines (2021)

Collectively, our data demonstrate that Onco-P20, exerting both a direct and an NHF-mediated indirect effect on carcinoma cells, is a candidate for an innovative therapy alternative to surgery for the treatment of NMSC.

Keyphrases

skin cancer
minimally invasive
electronic health record
cancer therapy
big data
machine learning
combination therapy
drug delivery